StockClub

KPTI

KPTIKaryopharm Therapeutics Inc.$ --
Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.

KPTI

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
34M USD
YoY +11.6%
Operating Income
-18M USD
YoY +43.0%
Net Income
-102M USD
YoY -232.0%
EPS
-5.68$
YoY -54.8%

Revenue

$146.1M
FY2024 Q1$33.1M
$33.1M
Q1
FY2024 Q2$75.9M
$75.9M
Q2
FY2024 Q3$114.7M
$114.7M
Q3
FY2024 Q4$145.2M
$145.2M
Q4
FY2025 Q1$30M
$30M
Q1
FY2025 Q2$67.9M
$67.9M
Q2
FY2025 Q3$112M
$112M
Q3
FY2025 Q4$146.1M
$146.1M
Q4
Actual
+$830,000 (+0.6%)

Net Income

$-196M
FY2024 Q1$-37.4M
$-37.4M
Q1
FY2024 Q2$-13.6M
$-13.6M
Q2
FY2024 Q3$-45.6M
$-45.6M
Q3
FY2024 Q4$-76.4M
$-76.4M
Q4
FY2025 Q1$-23.5M
$-23.5M
Q1
FY2025 Q2$-60.7M
$-60.7M
Q2
FY2025 Q3$-93.8M
$-93.8M
Q3
FY2025 Q4$-196M
$-196M
Q4
Actual
$-119.6M (-156.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$108.1M
Est:$101.4M
FY2020BEAT
$108.1M
FY2021BEAT
Actual:$209.8M
Est:$133.1M
FY2021BEAT
$209.8M
FY2022MISS
Actual:$157.1M
Est:$158M
FY2022MISS
$157.1M
FY2023BEAT
Actual:$146M
Est:$145.7M
FY2023BEAT
$146M
FY2024MISS
Actual:$145.2M
Est:$150.4M
FY2024MISS
$145.2M
FY2025MISS
Actual:$146.1M
Est:$147.1M
FY2025MISS
$146.1M

Analyst Estimates